BioSpace News Archive

Today, Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced the launch of its Care Management Suite, a patient-centric data- and analytics-driven approach to care management.

PainTEQ, a leading medical device innovator, announced the appointment of Michael Enxing, Chief Commercial Officer of Boston Scientific Corporation, Neuromodulation Division.

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced that 17 abstracts highlighting PyL™ (18F-DCFPyL) have been selected for presentation at the virtual Society of Nuclear Medicine and Molecular Imaging

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced it has closed an oversubscribed $30 mil

More than 8.5 million people in the U.S. today are living with chronic wounds at a cost to the U.S. healthcare system of $30 billion annually. Tissue Analytics, a Net Health company, recently presented a webinar to provide

Genome Medical , a leading telegenomics technology and services company democratizing access to genomic-based medicine, today announced that it has raised $14 million to expand its clinical genetics care and oper

BioNTech SE (Nasdaq: BNTX, “BioNTech”) will host a conference call and webcast today, July 1 st , 2020 at 11:00 a.m. EDT (5:00 p.m. CET) to discuss the preliminary data announced this morning from the ongoing Phase 1/2 trial of its mRNA-based vaccine program against SARS-CoV-2. To participate in the conference call, please dial the following numbers 10-15 minutes prior to the start of the call and provide the Conference ID: 7176269. Un

Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s past exposure to COVID-19 (SARS-CoV-2) in only 10 minutes. The serology-based, finger-prick tests detect virus antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms. The CE-IVD marked INgezim ® COVID-19 CROM dual-recognition immunochromato

Mentice AB announced the appointment of Thanos Karras as the company’s new General Manager for Americas.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home medical equipment, supplies and related services in the United States, announced today the upsizing and pricing of its previously announced underwritten public offering of 8,000,000 shares of its Class A Common Stock at a price to the public of $15.50 per share.